Cowen weighs in on Gevo (GEVO +20%), upgrading the stock to Outperform on the back of the U.S....

|By:, SA News Editor

Cowen weighs in on Gevo (GEVO +20%), upgrading the stock to Outperform on the back of the U.S. District Court's denial of Butamax's request for a preliminary injunction, and the announcement yesterday that it's collaborating to produce cellulosic isobutanol in Malaysia.